Table 1.
Summary of clinicopathological parameters of gastric cancer and their correlation with loss of MTSS1 protein expression
| Features | No. of patients (%) | Loss of MTSS1 expression (%) | P value |
|---|---|---|---|
| Tumor size | 0.005 | ||
| <6 cm | 825(77.0%) | 560(67.9%) | |
| ≥6 cm | 247(23.0%) | 191(77.3%) | |
| Site | NS | ||
| Cardia and fundus | 180(16.8%) | 127(70.6%) | |
| Corpus | 329(30.7%) | 229(69.6%) | |
| Antrum | 519(48.4%) | 359(69.2%) | |
| Whole | 44(4.1%) | 36(81.8%) | |
| pT stage | < 0.001 | ||
| T0-T2 | 312(29.1%) | 173(55.4%) | |
| T3/T4 | 760(70.9%) | 578(76.1%) | |
| pN stage | < 0.001 | ||
| N0 | 356(33.2%) | 205(57.6%) | |
| N1-3 | 716(66.8%) | 546(76.3%) | |
| Disease stage | < 0.001 | ||
| I/II | 427(39.8%) | 243(57%) | |
| III/IV | 645(60.2%) | 508(78.8%) | |
| Differentiation | < 0.001 | ||
| Well/Moderate | 634(59.1%) | 399(62.9%) | |
| Poorly | 438(40.9%) | 352(80.4%) | |
| Lauren's classification | < 0.001 | ||
| Intestinal-type | 618(57.6%) | 407(65.9%) | |
| Diffuse-type | 454(42.4%) | 344(75.8%) | |
| Total | 1072 | 751(70.1%) |